Trials / Conditions / Transthyretin (TTR) Amyloid Cardiomyopathy
Transthyretin (TTR) Amyloid Cardiomyopathy
6 registered clinical trials studyying Transthyretin (TTR) Amyloid Cardiomyopathy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Pa NCT07196839 | University of Texas Southwestern Medical Center | — |
| Active Not Recruiting | An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-ca NCT07062848 | Yale University | — |
| Completed | Vyndaqel Capsules Special Investigation (ATTR-CM) NCT04108091 | Pfizer | — |
| Enrolling By Invitation | PL_GNT01_ISR_Grant 53234273 NCT06714019 | National Institute of Cardiology, Warsaw, Poland | — |
| Completed | Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy NCT02791230 | Pfizer | Phase 3 |
| Completed | Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy NCT01994889 | Pfizer | Phase 3 |